The variability of female reproductive ageing.

Department of Reproductive Medicine, University Medical Centre, Utrecht, The Netherlands.
Human Reproduction Update (Impact Factor: 8.66). 8(2):141-54.
Source: PubMed

ABSTRACT The delay in childbearing is an important societal change contributing to an increasing incidence of subfertility. The prevailing concept of female reproductive ageing assumes that the decline of both quantity and quality of the oocyte/follicle pool determines an age-dependent loss of female fertility. There is an apparent discrepancy between the ability to maintain a regular ovulatory cycle pattern and the several years earlier cessation of female fertility. This latter is largely explained by an age-related increase of meiotic non-disjunction leading to chromosomal aneuploidy and early pregnancy loss, such that most embryos from women > or =40 years old are chromosomally abnormal and rarely develop further. The final stage of reproductive ageing-the occurrence of menopause-shows a huge variation between women. Age at last birth in natural fertility populations, which marks the end of female fertility, shows an identically wide variation as age at menopause, but occurs on average 10 years earlier. Given the high heritability for age at menopause, the variation in both age of menopause and last birth are probably under genetic control by the same set of genes. Some of those genes must carry heritable variants which modulate the rate of ovarian ageing and give rise to the wide age variations for the various phases of reproductive ageing.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose Thyroid dysfunction and autoimmune thyroiditis are associated with fertility in women of reproductive age. Anti-Müllerian hormone (AMH), a known biomarker of ovarian function, may be affected by impaired thyroid function; however, the relationship between AMH and thyroid hormone has not been elucidated. Methods In this case–control study, to identify the impact of thyroid hormone on ovarian reserve, we recruited 67 consecutive Japanese infertile patients and 27 normal fertile women aged 30–39 years without impact factors on thyroid and ovarian functions between 2012 and 2013. We assessed patient age, BMI and AMH, prolactin, TSH and FT4 levels of all study participations as independent variables. To evaluate the relationship between AMH and thyroid hormone, we matched patients by age and body mass index as confounding factors using 1:1 matching for statistical analysis of healthy fertile women and infertile patients and obtained 23 pairs. Then, independent variables were subjected to multiple regression analysis. Results Multiple regression analysis showed that both thyroid-stimulating hormone (TSH) levels and patient age were negatively correlated with AMH levels in infertile patients (patient age and TSH: standardized partial regression coefficient (β), −0.534 and −0.361; p = 0.003 and 0.036, respectively), but not in normal fertile women. Conclusions AMH levels were inversely correlated with TSH levels in infertile women of reproductive age.
    Journal of Assisted Reproduction and Genetics 12/2014; · 1.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Viele Frauen, die die Familienplanung immer weiter hinausschieben, verdrängen die Tatsache, dass ihre Fertilität etwa ab dem 35. Lebensjahr drastisch sinkt. Was heute über die „Biologie des reproduktiven Alters“ bekannt ist und mit welchen Methoden Frauen im kritischen Alter doch noch zu einem eigenen Kind verholfen werden kann, ist Thema des folgenden Beitrags.
    MMW Fortschritte der Medizin 07/2012; 154(13):47-50.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Reproductive senescence is a hallmark of aging. The molecular mechanisms regulating reproductive senescence and its association with the aging of somatic cells remain poorly understood. From a full genome RNA interference (RNAi) screen, we identified 32 Caenorhabditis elegans gene inactivations that delay reproductive senescence and extend reproductive lifespan. We found that many of these gene inactivations interact with insulin/IGF-1 and/or TGF-β endocrine signaling pathways to regulate reproductive senescence, except nhx-2 and sgk-1 that modulate sodium reabsorption. Of these 32 gene inactivations, we also found that 19 increase reproductive lifespan through their effects on oocyte activities, 8 of them coordinate oocyte and sperm functions to extend reproductive lifespan, and 5 of them can induce sperm humoral response to promote reproductive longevity. Furthermore, we examined the effects of these reproductive aging regulators on somatic aging. We found that 5 of these gene inactivations prolong organismal lifespan, and 20 of them increase healthy life expectancy of an organism without altering total life span. These studies provide a systemic view on the genetic regulation of reproductive senescence and its intersection with organism longevity. The majority of these newly identified genes are conserved, and may provide new insights into age-associated reproductive senescence during human aging.
    PLoS Genetics 12/2014; 10(12):e1004752. · 8.17 Impact Factor

Full-text (2 Sources)

Available from
Jun 10, 2014